In June 2024, phase III SURMOUNT-OSA trial data from Eli Lilly highlights the potential of GLP-1s in managing OSA. The trial compared the efficacy of GLP-1s alone and in combination with positive airway pressure (PAP) over 12 months. The combination therapy showed a 62.8% reduction in apnea-hypopn...Read More »
August 13, 2024
The U.S. integrated delivery network market size was estimated at USD 1.92 trillion in 2023 and is expected to expand at a CAGR of 10.25% from 2024 to 2030. The study covers integrated delivery networks in the U.S. which helps to understand details regarding their corporate executive names, design...Read More »
August 13, 2024
Cell therapies have emerged as a leading sector in the biopharmaceutical industry, marked by significant advancements toward potentially curative treatments for complex diseases using innovative scientific approaches. This field has recently seen a surge in billion-dollar investments and numerous ...Read More »
August 13, 2024
The COVID-19 pandemic brought mRNA vaccines to the forefront, highlighting their rapid development and high efficacy in addressing urgent health needs. While the focus has largely been on COVID-19 vaccines, a significant amount of research is being conducted on mRNA vaccines for cancer treatment.<...Read More »
August 13, 2024
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. We have actively been tracking the CDMOs space and have seen the evolution of these players from just a handful to now over 100 companies.
...Read More »August 13, 2024
The U.S. hospital facilities market size was valued at USD 1,411.7 billion in 2022 and is expected to grow at a CAGR of 7.7% from 2023 to 2030. The study covers hospitals at state & county level which helps to understand details regarding their location, address, ownership, and other parameter...Read More »
August 13, 2024
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. We have actively been tracking the CDMOs space and have seen the evolution of these players from just a handful to now over 100 companies.
...Read More »August 12, 2024
Diabetic foot ulcer is a severe complication of diabetes mellitus, associated with high morbidity, mortality, and reduced quality of life. The incidence of diabetic foot ulcer (DFU) continues to rise. Among the estimated 537 million people globally living with diabetes, between 19% and 34% are exp...Read More »
August 12, 2024
Our healthcare outsourcing portfolio has been developing since our inception in 2014, wherein we have been continuously tracking several sub-domains such as clinical trials, CRO, CDMO, CMO, and specialty service providers space and their R&D activities, financial performance, strategic initiat...Read More »
August 12, 2024
Our healthcare portfolio has been developing since our inception in 2014, wherein we have tracked numerous sub-domains and their R&D activities. We have actively been tracking the sequencing technology space and have seen the evolution of these players over time. To help understand and highlig...Read More »
August 12, 2024
Key factors driving the research, development, and launch of gene therapy products include increasing regulatory support, patient demand, technological advancements in gene editing techniques, and market potential for innovative treatments for chronic diseases. Gene therapies hold significant prom...Read More »
August 12, 2024
The malaria diagnostics market is evolving rapidly with a growing emphasis on point-of-care testing (POCT) for quick and accurate results, crucial for remote areas. Innovations such as the microfluidic point-of-care immunoassay highlight significant advancements, delivering results in just 15 minu...Read More »
August 12, 2024
Technological advancements in drug delivery devices are driven by the need for better patient compliance, improved therapeutic outcomes, and personalized treatments. The growing prevalence of diabetes and cardiovascular diseases (CVD), coupled with the rise in biologic drug development, has spurre...Read More »
August 12, 2024
The global in vitro diagnostics quality control market size was estimated at USD 1.28 billion in 2023 and is projected to grow at a CAGR of 3.2% from 2024 to 2030. An increasing number of accredited clinical laboratories worldwide and the presence of favorable regulatory policies are expected to d...Read More »
August 8, 2024
The competitive analysis of the ophthalmic devices industry in the U.S. is driven by several key factors. The aging population significantly impacts market growth as conditions like cataracts, glaucoma, and age-related macular degeneration become more prevalent, increasing the demand for diagnosti...Read More »
August 8, 2024
The global healthcare assistive robots market size was estimated at USD 27.3 billion in 2023 and is projected to grow at a CAGR of 16.6% from 2024 to 2030. The market encompasses a range of segments such as surgical, exoskeleton, pharmaceutical, cleanroom, prosthetics, medical service, and companion robots.
...Read More »August 8, 2024
The brand market share & geographic mapping for top 50 manufacturers in medical device sector trend report focuses on brands of medical devices and equipment used in a wide range of applications, such as orthopedic; ophthalmic; dental care; Ear, Nose, and Throat (ENT); wound care; urology and ...Read More »
August 8, 2024
The competitiveness of key players in the medical foods market is influenced by the ability to innovate, navigate regulatory landscape, maintain high quality and effectively market their products. The leaders invest significantly in the R&D, leverage strong brand reputation and extensive netwo...Read More »
August 8, 2024
The use of disposable and single-use devices in general surgery has risen dramatically, driven by concerns about patient safety and the convenience of pre-sterilized instruments. However, this trend is facing challenges due to high costs and environmental impact. As a result, a counter-trend is em...Read More »
August 7, 2024
The U.S. pharmaceutical market size was estimated at USD 574.37 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.48% from 2024 to 2030. Despite the setback due to COVID-19 in certain application areas, the pharmaceutical companies have remained agile. Key player...Read More »
August 7, 2024